Educational materials as part of a Risk Management Plan (RMP) are important for raising awareness about the safe and effective use of medicines. These materials are designed for healthcare professionals, patients, and caregivers. They provide clear information about the risks associated with medicine use and how to manage them for the best treatment outcomes. 
It's important to note that these materials are not a duplicate of Production Information (PI) or Consumer Medicine Information (CMI) and may not be available for all medicines.

Novartis Pharmaceuticals' RMP educational materials in Australia can be found on this page. This information is specifically for use in Australia and should not replace advice from a healthcare professional. 
For further questions or concerns, please contact your healthcare professional or Novartis Medical Information at 1800 671 203.

AU-26192, date of preparation: May-2024